The House Appropriations Committee is requesting that the FDA holds off on regulating laboratory developed tests. A recent report finds that private equity-backed providers account for less than 4 percent of the U.S. provider market by revenue. And a new study links semaglutide to lower risk for both dementia and nicotine use. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
